These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8645090)

  • 1. Pathogenicity and vaccine efficacy of a thymidine kinase-deficient mutant of feline herpesvirus type 1 in cats.
    Yokoyama N; Maeda K; Tohya Y; Kawaguchi Y; Shin YS; Ono M; Ishiguro S; Fujikawa Y; Mikami T
    Arch Virol; 1996; 141(3-4):481-94. PubMed ID: 8645090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine efficacy of recombinant feline herpesvirus type 1 expressing immunogenic proteins of feline calicivirus in cats.
    Yokoyama N; Maeda K; Fujita K; Ishiguro S; Sagawa T; Mochizuki M; Tohya Y; Mikami T
    Arch Virol; 1996; 141(12):2339-51. PubMed ID: 9526541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further development of a recombinant feline herpesvirus type 1 vector expressing feline calicivirus immunogenic antigen.
    Yokoyama N; Fujita K; Damiani A; Sato E; Kurosawa K; Miyazawa T; Ishiguro S; Mochizuki M; Maeda K; Mikami T
    J Vet Med Sci; 1998 Jun; 60(6):717-23. PubMed ID: 9673943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoproteins gl and gE of feline herpesvirus-1 are virulence genes: safety and efficacy of a gl-gE deletion mutant in the natural host.
    Kruger JM; Sussman MD; Maes RK
    Virology; 1996 Jun; 220(2):299-308. PubMed ID: 8661381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A feline herpesvirus-1 recombinant with a deletion in the genes for glycoproteins gI and gE is effective as a vaccine for feline rhinotracheitis.
    Sussman MD; Maes RK; Kruger JM; Spatz SJ; Venta PJ
    Virology; 1995 Dec; 214(1):12-20. PubMed ID: 8525607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of the recombinant feline herpesvirus type 1 deleted thymidine kinase gene.
    Yokoyama N; Maeda K; Kawaguchi Y; Ono M; Tohya Y; Mikami T
    J Vet Med Sci; 1995 Aug; 57(4):709-14. PubMed ID: 8519903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of cats for feline rhinotracheitis results in a quantitative reduction of virulent feline herpesvirus-1 latency load after challenge.
    Sussman MD; Maes RK; Kruger JM
    Virology; 1997 Feb; 228(2):379-82. PubMed ID: 9123845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant feline herpesvirus type 1 expressing immunogenic proteins inducible virus neutralizing antibody against feline calicivirus in cats.
    Yokoyama N; Maeda K; Tohya Y; Kawaguchi Y; Fujita K; Mikami T
    Vaccine; 1996 Dec; 14(17-18):1657-63. PubMed ID: 9032896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a TK/ gI/gE gene-deleted feline herpesvirus-1 mutant constructed via CRISPR/Cas9 in feline.
    Yang M; Jiao Y; Yan Y; Li L; Hu X; Jiao Z; Li M; Chen Y; Shi Y; Shen Z; Peng G
    Vet Microbiol; 2023 Jun; 281():109728. PubMed ID: 37003192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a live attenuated intranasal vaccine on latency and shedding of feline herpesvirus 1 in domestic cats.
    Weigler BJ; Guy JS; Nasisse MP; Hancock SI; Sherry B
    Arch Virol; 1997; 142(12):2389-400. PubMed ID: 9672602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
    Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
    Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a recombinant feline herpesvirus type 1 expressing Gag precursor protein of feline immunodeficiency virus.
    Sato E; Yokoyama N; Maeda K; Inoshima Y; Kohmoto M; Ikeda Y; Miyazawa T; Mikami T
    Arch Virol; 1998; 143(3):453-66. PubMed ID: 9572547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo properties of a feline herpesvirus type 1 mutant carrying a lacZ insertion at the gI locus of the unique short segment.
    Willemse MJ; Chalmers WS; Sondermeijer PJ
    Vaccine; 1996 Jan; 14(1):1-5. PubMed ID: 8821641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial.
    Jas D; Frances-Duvert V; Vernes D; Guigal PM; Poulet H
    Vet Microbiol; 2015 May; 177(1-2):123-31. PubMed ID: 25824128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of an intranasal combined feline viral rhinotracheitis, feline calicivirus vaccine and the FVR carrier state.
    Orr CM; Gaskell CJ; Gaskell RM
    Vet Rec; 1980 Feb; 106(8):164-6. PubMed ID: 6244692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral replication and innate immunity of feline herpesvirus-1 virulence-associated genes in feline respiratory epithelial cells.
    Lee Y; Maes R; Tai SS; Soboll Hussey G
    Virus Res; 2019 Apr; 264():56-67. PubMed ID: 30796929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline herpesvirus.
    Gaskell R; Dawson S; Radford A; Thiry E
    Vet Res; 2007; 38(2):337-54. PubMed ID: 17296160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenicity and immunogenicity of gI/gE/TK-gene-deleted Felid herpesvirus 1 variants in cats.
    Tang A; Zhu M; Zhu J; Zhang D; Zhu S; Wang X; Meng C; Li C; Liu G
    Virol J; 2023 May; 20(1):87. PubMed ID: 37143065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Felid Herpesvirus-1 Deletion Mutants in Cats.
    Lee Y; Maes RK; Kruger JM; Kiupel M; Giessler KS; Soboll Hussey G
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33499363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a feline viral rhinotracheitis-feline calicivirus disease vaccine.
    Scott FW
    Am J Vet Res; 1977 Feb; 38(2):229-34. PubMed ID: 190925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.